Keyword: Sanofi takeover bid Genzyme
News
14.01.2011
- French drugmaker Sanofi-Aventis hopes to reach a takeover deal that would value U.S. target Genzyme at around $76 per share, or some $20 billion, the French daily newspaper Le...
News
13.01.2011
- French drugmaker Sanofi-Aventis won European Union regulatory approval on Wednesday for its hostile $18.5 billion takeover bid for U.S. biotech firm Genzyme. The European...
